Norden Group’s AstraZeneca AZN Stock Holding History

Norden Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$659K	Sell	3,475 -216	-6%	-$40.6K	0.05%	295
2026 Q1	$728K	Buy	3,691 +62	+2%	+$12K	0.07%	244
2025 Q4	$667K	Sell	3,629 -405	-10%	-$71K	0.07%	280
2025 Q3	$619K	Buy	4,034 +646	+19%	+$97.8K	0.06%	293
2025 Q2	$474K	Sell	3,388 -134	-4%	-$18.8K	0.05%	352
2025 Q1	$518K	Sell	3,522 -1,251	-26%	-$181K	0.06%	304
2024 Q4	$625K	Buy	4,773 +275	+6%	+$38.5K	0.07%	295
2024 Q3	$701K	Buy	4,498 +2,032	+82%	+$328K	0.08%	263
2024 Q2	$385K	Buy	2,466 +587	+31%	+$88.3K	0.08%	261
2024 Q1	$255K	Buy	+1,879	New	+$249K	0.05%	344

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norden Group's AZN Position: Q2 2026 in Review

Norden Group reduced its AstraZeneca (AZN) stake by 5.9% in Q2 2026, selling an estimated $40.6K and leaving 3,475 shares worth $659K. The position accounts for 0.05% of the portfolio, ranked #295.

Norden Group first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $728K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Norden Group held 3,475 shares of AstraZeneca worth $659K as of Q2 2026.
Norden Group sold 216 AstraZeneca shares in Q2 2026, an estimated $40.6K.
AstraZeneca made up 0.05% of Norden Group's portfolio in Q2 2026, its #295 holding.
Norden Group first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
Norden Group's AstraZeneca position peaked at $728K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.